Veeco Instruments Inc. (VECO)

Q: What's priced into Veeco Instruments Inc. (VECO) stock?

VECO is expensive versus peers, with a 1.47 premium measure and a modestly negative expectations gap. The priced-in assessment is tagged justified, with low fragility; that means the snapshot does not show a strong case that expectations are unusually vulnerable to disappointment.

Q: What does the Veeco Instruments Inc. (VECO) outlook hinge on?

Over the next few quarters, the thesis depends on sustaining AI and high-performance computing demand and delivering against 2026 guidance. A guidance cut would be a meaningful negative; merger completion on the stated timeline would support execution, while delays would leave an important priority unresolved. Rate cuts and continued strength from sector bellwethers such as NVDA, TSM, and AVGO are possible sector tailwinds, not proof of company-specific progress.

NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-23

$42.06+2.21%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Veeco Instruments Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Gross margin	42%non-GAAP	—
FY 2026 · Q4
Revenue	—	235.05M
EPS	—	0.605
FY 2026 · Annual
Revenue	$810Mnon-GAAP	800.19M
EPS	$0.2–$0.32non-GAAP	1.5
Gross margin	42%non-GAAP	—
FY 2027 · Annual
Revenue	—	1.11B
EPS	—	3.167

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Non-GAAP diluted EPS reaches at least $1.50 in 2026	A primary condition in Veeco Instruments Inc.'s published investment case. The stated target is >= $1.50 per share.	Broken	EPS falls below $1.50 in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Q2 2026 revenue reaches at least $170 million	A supporting condition in Veeco Instruments Inc.'s published investment case. The stated target is >= $170 million.	Broken	Q2 2026 revenue falls below $170 million	Revenue: $193.481M FY2026-Q2; GAAP. Published target: >= $170 million. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 5, 2026193,481,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 483c8365-c382-4a70-a55b-58ba19d000a9. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Annual revenue reaches at least $740 million in 2026	A primary condition in Veeco Instruments Inc.'s published investment case. The stated target is >= $740 million.	Broken	Annual revenue falls below $740 million in FY26	Revenue: $193.481M FY2026-Q2; GAAP. Published target: >= $740 million. Target period is not explicitly aligned with this observation. Source published Aug 5, 2026193,481,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 483c8365-c382-4a70-a55b-58ba19d000a9. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Price remains within 20% above fair value	A supporting condition in Veeco Instruments Inc.'s published investment case. The stated target is <= 20% above fair value.	Broken	Price exceeds 20% above fair value for more than one month	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPSUnavailable

Unavailable → Unavailable · observed estimates

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	Unavailable	2 / 3
2026-07-25	$3.04	Unavailable	5 / 4
2026-07-26	Unavailable	Unavailable	2 / 3
2026-07-27	$3.04	Unavailable	5 / 4
2026-07-28	$3.04	Unavailable	5 / 4
2026-07-29	Unavailable	Unavailable	2 / 3
2026-07-30	$3.04	Unavailable	5 / 4
2026-07-31	$3.04	Unavailable	5 / 4
2026-08-01	Unavailable	Unavailable	2 / 3
2026-08-02	Unavailable	Unavailable	2 / 3
2026-08-03	$3.04	Unavailable	5 / 4
2026-08-04	$3.04	Unavailable	5 / 4
2026-08-05	Unavailable	Unavailable	2 / 3
2026-08-06	Unavailable	Unavailable	2 / 3
2026-08-08	Unavailable	Unavailable	2 / 3
2026-08-09	$3.04	Unavailable	5 / 4
2026-08-10	$3.04	Unavailable	5 / 4
2026-08-12	Unavailable	Unavailable	2 / 3
2026-08-13	$2.92	Unavailable	5 / 4
2026-08-14	Unavailable	Unavailable	2 / 3
2026-08-15	Unavailable	Unavailable	2 / 3
2026-08-16	Unavailable	Unavailable	2 / 3
2026-08-17	Unavailable	Unavailable	2 / 3
2026-08-18	Unavailable	Unavailable	2 / 3
2026-08-19	Unavailable	Unavailable	2 / 3
2026-08-20	Unavailable	Unavailable	2 / 3
2026-08-21	Unavailable	Unavailable	2 / 3
2026-08-22	Unavailable	Unavailable	2 / 3
2026-08-23	Unavailable	Unavailable	2 / 3
2026-08-24	Unavailable	Unavailable	2 / 3
2026-08-25	Unavailable	Unavailable	2 / 3
2026-08-26	Unavailable	Unavailable	2 / 3
2026-08-27	Unavailable	Unavailable	2 / 3
2026-08-28	Unavailable	Unavailable	2 / 3
2026-08-29	Unavailable	Unavailable	2 / 3
2026-08-30	Unavailable	Unavailable	2 / 3
2026-08-31	Unavailable	Unavailable	2 / 3
2026-09-01	Unavailable	Unavailable	2 / 3
2026-09-02	Unavailable	Unavailable	2 / 3
2026-09-03	Unavailable	Unavailable	2 / 3
2026-09-04	Unavailable	Unavailable	2 / 3
2026-09-05	Unavailable	Unavailable	2 / 3
2026-09-06	Unavailable	Unavailable	2 / 3
2026-09-07	Unavailable	Unavailable	2 / 3
2026-09-08	Unavailable	Unavailable	2 / 3
2026-09-09	Unavailable	Unavailable	2 / 3
2026-09-10	Unavailable	Unavailable	2 / 3
2026-09-11	Unavailable	Unavailable	2 / 3
2026-09-12	Unavailable	Unavailable	2 / 3
2026-09-13	Unavailable	Unavailable	2 / 3
2026-09-14	Unavailable	Unavailable	2 / 3
2026-09-15	Unavailable	Unavailable	2 / 3
2026-09-16	Unavailable	Unavailable	2 / 3
2026-09-17	Unavailable	Unavailable	2 / 3
2026-09-18	Unavailable	Unavailable	2 / 3
2026-09-19	Unavailable	Unavailable	2 / 3
2026-09-20	Unavailable	Unavailable	2 / 3
2026-09-21	Unavailable	Unavailable	2 / 3
2026-09-22	Unavailable	Unavailable	2 / 3
2026-09-23	Unavailable	Unavailable	2 / 3
2026-09-24	Unavailable	Unavailable	2 / 3
2026-09-25	Unavailable	Unavailable	2 / 3
2026-09-26	Unavailable	Unavailable	2 / 3
2026-09-27	Unavailable	Unavailable	2 / 3
2026-09-28	Unavailable	Unavailable	2 / 3
2026-09-29	Unavailable	Unavailable	2 / 3
2026-09-30	Unavailable	Unavailable	2 / 3
2026-10-01	Unavailable	Unavailable	2 / 3
2026-10-02	Unavailable	Unavailable	2 / 3
2026-10-03	Unavailable	Unavailable	2 / 3
2026-10-04	Unavailable	Unavailable	2 / 3
2026-10-05	Unavailable	Unavailable	2 / 3
2026-10-06	Unavailable	Unavailable	2 / 3
2026-10-07	Unavailable	Unavailable	2 / 3
2026-10-08	Unavailable	Unavailable	2 / 3
2026-10-09	Unavailable	Unavailable	2 / 3
2026-10-10	Unavailable	Unavailable	2 / 3
2026-10-11	Unavailable	Unavailable	2 / 3
2026-10-12	Unavailable	Unavailable	2 / 3
2026-10-13	Unavailable	Unavailable	2 / 3
2026-10-14	Unavailable	Unavailable	2 / 3
2026-10-15	Unavailable	Unavailable	2 / 3
2026-10-16	Unavailable	Unavailable	2 / 3
2026-10-17	Unavailable	Unavailable	2 / 3
2026-10-18	Unavailable	Unavailable	2 / 3
2026-10-19	Unavailable	Unavailable	2 / 3
2026-10-20	Unavailable	Unavailable	2 / 3
2026-10-21	Unavailable	Unavailable	2 / 3
2026-10-22	Unavailable	Unavailable	2 / 3
2026-10-23	Unavailable	Unavailable	2 / 3
2026-10-24	Unavailable	Unavailable	2 / 3

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	1	3
2026-06-01	1	3
2026-07-01	1	3
2026-08-01	1	3
2026-09-01	2	3
2026-10-01	2	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 2 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

OppenheimerOct 14

$24.00New observation · no comparable prior

$0$13.20$26.40

0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Non-GAAP diluted EPS reaches at least $1.50 in 2026Published status: Broken
Q2 2026 revenue reaches at least $170 millionPublished status: Broken
Annual revenue reaches at least $740 million in 2026Published status: Broken
Price remains within 20% above fair valuePublished status: Broken

Next proof point

Nov 4, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

3.0%Typical daily move · historical

Downside history

-50.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Veeco Instruments Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a growth-oriented semiconductor equipment business, with recent revenue growth tied to AI and high-performance computing demand. The long-term thesis is intact, but the risk rating is high and the evidence on earnings quality and management is neutral.

What's priced into Veeco Instruments Inc.

VECO is expensive versus peers, with a 1.47 premium measure and a modestly negative expectations gap. The priced-in assessment is tagged justified, with low fragility; that means the snapshot does not show a strong case that expectations are unusually vulnerable to disappointment.

What the fundamentals likely do

Near term, revenue rose from $158.3 million in 2026-Q1 to $193.5 million in 2026-Q2, and management reiterated 2026 revenue guidance of $740 million to $810 million. Delivery remains uncertain: VECO had two recent earnings misses followed by an August beat, while the risk rating recently moved from elevated to high. The merger with Axcelis is expected in the second half of 2026, subject to regulatory and shareholder approvals.

What Veeco Instruments Inc. hinges on